If your billing company files No Surprises Act disputes for emergency physicians, anesthesia groups, or radiology practices, you probably have the fastest growing service line in your shop. You may also have the one a buyer will look at hardest. On October 1, 2026, CMS brought every certified independent dispute resolution (IDR) entity into one room with the CMS Administrator and Department of Labor leadership. The stated reason was the “increasingly high IDR-associated costs” the process is placing on the health system (CMS readout, October 1, 2026).
That meeting is the newest signal in a year of them. A final rule rewriting how the federal IDR process works took effect on August 3, 2026. A new IDR Gateway replaces the current portal in late 2026. For an owner thinking about selling, the practical question is simple: when a buyer looks at your No Surprises Act IDR revenue, what will they pay for it, and what will they discount?
This guide answers that from the federal data. It covers what the numbers say, how a buyer tears apart IDR revenue in diligence, and what you can do in the next twelve months so that line of business adds value instead of putting a question mark over the whole company.
What the federal IDR process is, in one paragraph
The No Surprises Act protects patients from most surprise out-of-network bills. When an out-of-network provider and a health plan cannot agree on payment for a covered service, either side can take the dispute to federal arbitration after a 30 business day open negotiation period. A certified IDR entity picks one of the two final offers. Since the process opened in April 2022, it has received and closed more than 7 million disputes, a volume CMS itself describes as “far exceeding expectations” (CMS readout). A large share is filed by representatives rather than by clinicians themselves, which is why CMS reports its top filers as “initiating parties or their representatives.” Those representatives are billing companies, RCM firms, and specialty management companies.
The numbers a buyer will start with
CMS publishes quarterly supplemental tables on the federal IDR process. The most recent quarters with full tables are the first two of 2025. Here is what they show (CMS Federal IDR Supplemental Tables, 2025 Q1 and 2025 Q2):
| Measure, January to June 2025 | Figure | CMS table |
|---|---|---|
| Disputes initiated | 1,186,812 | Table 1 |
| Growth, Q2 over Q1 | 17.6% | Table 1 |
| Payment determinations made | 1,082,247 | Table 12 |
| Determinations won by the provider, facility, or air ambulance side | 951,170 (87.9%) | Table 12 |
| Determinations where only one party submitted an offer | 242,922 (22.4%) | Table 12 |
| Disputes challenged as ineligible by the other side | 476,117 (40.1%) | Table 4 |
| Disputes closed as found ineligible | 229,457 (17.0% of closures) | Table 5 |
Read the first two rows together and you can see why IDR became a business. Volume is growing quickly, and the side that initiates (almost always the provider) wins close to nine determinations in ten.
Now read the last three rows. They are what a buyer will focus on. More than one in five determinations was decided with only one offer on the table, which usually means the plan did not engage. Two in five disputes were challenged as ineligible. Roughly one closure in six ended with the dispute thrown out as ineligible. Those are the parts of IDR revenue that are most exposed to the rule changes now arriving.
Where the money comes from
The award is not paid in a lump. It is the difference between what the plan first paid and the offer the IDR entity selected. That spread is large in the specialties that file most often. In the second quarter of 2025, the median prevailing offer was 312% of the qualifying payment amount (QPA) for emergency department services, 312% for anesthesia, and 512% for radiology (CMS Supplemental Tables 2025 Q2, Table 14).
The QPA is, roughly, the plan’s median contracted rate for the same or similar service in that geographic area. An award at three or five times that benchmark is real money for the practice and, under most billing contracts, real money for the billing company too. Many IDR engagements are priced as a percentage of the recovered amount, and some are priced per dispute. Either way, the billing company’s revenue rises and falls with the arbitration result.
The process itself is not cheap. In the first half of 2025, certified IDR entities were paid $613.3 million and the Departments collected $230.5 million in administrative fees (CMS Supplemental Tables, Table 6). That cost is exactly what the October 1 meeting was about.
Small and mid-sized groups are a big part of this. In the second quarter of 2025, practices and facilities with 20 to 50 employees initiated 213,156 of the 630,830 non-air ambulance disputes, about 34% (Table 2). Those groups rarely run arbitration in house. They hire someone to do it, and that someone is often the kind of company reading this.
What changed in 2026
Three things changed this year. Together they reshape how a buyer will think about IDR revenue.
1. The Federal IDR Operations final rule. Published June 4, 2026 and effective August 3, 2026, the rule rewrites large parts of the process (91 FR 33900; correction at 91 FR 55462). Among the provisions:
- Plans must give more information about the QPA with the initial payment or denial.
- Plans must use claim adjustment reason codes (CARCs) and remittance advice remark codes (RARCs) on remittances to out-of-network providers. The exact codes and the compliance date come through guidance that the Departments said they intend to issue within six months of publication, with no less than four months to comply.
- The open negotiation, initiation, and eligibility review steps are amended.
- The rules for batching items and services, for bundled payment arrangements, and for administrative and IDR entity fees change.
- Plans and issuers must register in the federal IDR portal.
2. The IDR Gateway. CMS says the portal will be replaced by a new IDR Gateway that launches in late 2026 (CMS readout). Every company that files disputes will have to move its workflow, its integrations, and its staff onto a new system.
3. Regulators are looking at outcomes, not just backlogs. The October 1 readout lists the concerns that users raised about the process: “ineligible disputes, unclear IDR entity determination rationales, and delayed payment or nonpayment after certified IDR entity determinations.” It also says the Departments “will consider the insights” from the IDR entities “as they continue to explore all available regulatory and operational solutions.” That language does not announce a new rule. It does tell a buyer that more change is possible.
How a buyer takes IDR revenue apart in diligence
A buyer of a billing or RCM company will not treat IDR revenue like recurring monthly billing fees. Expect them to split it into pieces and price each piece on its own.
Recurring core versus event revenue. Monthly billing, coding, credentialing, and AR follow-up for a client is recurring. IDR fees depend on how many out-of-network claims your clients have, how many plans pay low, and how many awards you win. Buyers usually apply a lower multiple to that kind of revenue, or carve it out into an earnout, because they cannot see it repeating with the same confidence.
Eligibility rate. A buyer will want your ineligibility rate next to the national figure. Nationally, 17% of closures in early 2025 were dismissals for ineligibility. If your rate is far lower, that is evidence of disciplined intake. If it is higher, a buyer will assume part of your volume will not survive tighter eligibility review under the 2026 rule.
Default wins. If a meaningful share of your awards came from determinations where the plan never submitted an offer, a buyer will ask whether that continues. The 2026 rule requires plans to register in the IDR portal, and the readout shows regulators are watching how the process runs. A buyer is likely to model fewer uncontested wins going forward than you have seen in the past.
Collection, not just award. An award is not cash. The readout names “delayed payment or nonpayment after certified IDR entity determinations” as a known problem. A buyer will ask for the dollars awarded, the dollars collected, and the age of anything still open, by plan. If you cannot produce that schedule, a buyer will assume the gap is worse than it is.
Concentration, twice over. Your client concentration matters, and IDR adds a second layer. Disputes cluster by specialty, by state, and by plan. If most of your IDR revenue comes from one emergency medicine group in one state against two plans, a buyer sees three single points of failure stacked on top of each other.
Who owns the work. Engagement letters should say plainly who initiates the dispute, who signs, how fees are calculated, and what happens to open disputes if the client leaves. Buyers read these line by line. Vague letters lead to escrows and holdbacks.
A worked example (hypothetical)
Here is an illustration with made-up numbers. Take a billing company with $6 million in annual revenue. $4.5 million comes from recurring billing and coding fees, and $1.5 million comes from IDR contingency fees.
| Line | Revenue | How a buyer may treat it |
|---|---|---|
| Recurring billing, coding, AR | $4.5M | Valued on normalized earnings at the company’s core multiple |
| IDR fees, collected and documented | $1.0M | Valued, often at a discount to the core |
| IDR fees, awarded but uncollected or from default wins | $0.5M | Often moved to an earnout or excluded |
The owner may think of this as a $6 million company. A buyer may underwrite it as a $4.5 million company with an IDR option attached. The gap between those two views is where most of the negotiation happens. A clean, documented IDR line narrows the gap. A messy one widens it.
How the IDR line shows up in deal structure
Price is only part of it. When buyers are unsure about a revenue line, they usually move it into the structure of the deal instead of walking away. With IDR revenue, three tools come up often.
- Earnouts. Part of the price is paid later if IDR collections hit an agreed level over the next 12 to 24 months. The seller keeps the upside but carries the regulatory risk.
- Escrows and holdbacks. A share of the price sits in escrow against open disputes, refunds, or client claims tied to past filings.
- Working capital adjustments. Awarded but uncollected IDR receivables may be left out of the working capital target, or counted only at a discount.
Each of these is negotiable. In our experience, a seller who brings a clean, reconciled IDR file to the first meeting has a stronger hand on all three than one who produces the data piece by piece after the letter of intent.
What to do in the twelve months before you go to market
Most of this work is reporting you can produce from the data you already keep.
- Separate your revenue lines in the financials. Report IDR fees apart from recurring billing on the profit and loss statement. Show 24 to 36 months of history by quarter.
- Build an IDR performance file. By client, specialty, state, and plan, show disputes filed, found ineligible, determinations, wins, default wins, dollars awarded, dollars collected, and days to collection.
- Benchmark yourself against CMS. Put your ineligibility rate and win rate next to the national figures above. A buyer will do it anyway. Doing it first lets you explain the differences.
- Tighten intake now. Document your eligibility screen, including the open negotiation record, timing checks, and batching logic, against the 2026 rule. Lower ineligibility is the single clearest sign of a durable IDR practice.
- Get ready for the Gateway. Write down who will migrate your workflow and integrations to the IDR Gateway and when. A buyer does not want to fund a systems project in the first ninety days.
- Clean up engagement letters. Make fee terms, authority to file, and treatment of open disputes at termination explicit for every client.
- Grow the recurring core. Every dollar of recurring billing revenue you add reduces how much the IDR line drives your price.
- Get an outside read early. An advisor who has seen how buyers underwrite contingent revenue can tell you which of these steps matter most for your mix before a buyer tells you at the LOI.
What the IDR line does not decide
IDR revenue will not define your value on its own. A buyer still prices the core billing business on client retention, contract terms, staffing model, technology, and margin. Our earlier pieces on AI and the CMS prior authorization rules and on client concentration cover those drivers. Think of the IDR line as a multiplier on uncertainty. When it is documented it can add value. When it is not, it can pull down a price that the rest of the business has earned.
Where Vallexa fits
Vallexa Advisors works on the sell side for healthcare services owners, including medical billing and revenue cycle management companies. Our current marketed opportunities skew toward agencies, such as a CHAP-accredited Minnesota hospice. The same buyer network includes groups that acquire the billing and RCM firms serving those providers. If you want to see how your IDR line would look to a buyer, start with our exit preparation guide or talk with an advisor in confidence.
Frequently asked questions
Most buyers separate it from recurring billing fees. Documented, collected IDR fees are usually valued at a discount to the core business, and awarded but uncollected amounts or default wins are often moved into an earnout. Clean reporting by client, plan, and outcome narrows that discount.
In the first half of 2025, the provider, facility, or air ambulance side prevailed in 951,170 of 1,082,247 payment determinations, or 87.9 percent, according to CMS Federal IDR Supplemental Tables for 2025 Q1 and Q2. In 22.4 percent of determinations, only one party submitted an offer.
The Federal IDR Operations final rule (91 FR 33900) took effect August 3, 2026. It changes QPA disclosures, open negotiation, initiation, eligibility review, batching, and fees, requires plans to register in the IDR portal, and requires remittance codes on payments to out-of-network providers once guidance sets the date. CMS also says a new IDR Gateway launches in late 2026.
It shows how much of your dispute volume survives review. Nationally, 40.1 percent of disputes in early 2025 were challenged as ineligible and 17.0 percent of closures were dismissals for ineligibility. A rate well below that signals disciplined intake; a higher rate suggests volume a buyer may not pay for.
Report IDR fees separately on the profit and loss statement for 24 to 36 months, build a file of disputes, eligibility results, wins, default wins, dollars awarded and collected by client and plan, document intake against the 2026 rule, plan the IDR Gateway migration, and tighten engagement letters on fees and open disputes.
Sources
- Centers for Medicare & Medicaid Services, Federal IDR Supplemental Tables, 2025 Q1 and 2025 Q2, Tables 1, 2, 4, 5, 6, 12, and 14, from the CMS Independent Dispute Resolution Reports page.
- Centers for Medicare & Medicaid Services, CMS Convenes Certified Independent Dispute Resolution Entity Leaders to Discuss Ways to Improve the Federal Program, October 1, 2026.
- Departments of the Treasury, Labor, and Health and Human Services and the Office of Personnel Management, Federal Independent Dispute Resolution Operations, final rules, 91 FR 33900, June 4, 2026, effective August 3, 2026.
This article is general information for business owners. It is not legal, tax, or investment advice. Rules on the federal IDR process are changing; confirm current requirements with counsel before acting.


